PRP groups significantly (P<0.05) decreased serum levels of FSH, LH, testosterone and androstenedioneand remarkably (P<0.05) increased estrogen and progesterone syntheses versus PCOS-sole groups. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.